| IDORSIA AG SF-,05 |
| Schweiz |
| Gesundheit |
| CH0363463438 / A2DTEB |
| 19T (Frankfurt) |
| FRA:19T, ETR:19T, 19T:GR |
| - |
| https://www.idorsia.com/ |
|
Idorsia Ltd is a Swiss biopharmaceutical company headquartered in Allschwil near Basel, specializing in the discovery, development, and commercialization of innovative small-molecule medicines for unmet medical needs. Its purpose is to transform ther..
>Volltext.. |
| 1688.27 Mio. EUR |
| 3042.26 Mio. EUR |
| 213.75 Mio. EUR |
| -156.66 Mio. EUR |
| -338.41 Mio. EUR |
| -1.4 EUR |
| 1437.2 Mio. EUR |
| 94.92 Mio. EUR |
| -133.71 Mio. EUR |
| 0.23 |
| -6.92% |
| -140.14% |
| - |
| - |
| - |
| - |
| IDORSIA |
| 11.08.26 |
|
||||
|
||||
|
||||
|
||||
|